by AIP Online Bureau | Sep 22, 2025 | Eco/Invest/Demography, Health, Indian News, Risk Management
Additionally, the state drugs testing laboratories identified 62 samples as “not of standard quality” (NSQ) in the month under review, they said. In August, three drug samples from Bihar were identified as spurious, which were manufactured by an unauthorised...
by AIP Online Bureau | Jul 19, 2025 | Data, Eco/Invest/Demography, Health, Policy, Regulation, Risk Management
These drugs were manufactured by an unauthorized entity using a brand name owned by another company, and the matter is under investigation and action will be taken in accordance with relevant rules. New Delhi: The central drugs laboratories have found 55 samples...
by AIP Online Bureau | Jul 7, 2025 | Eco/Invest/Demography, Health, Indian News
The Indian obesity drug market has grown fivefold since 2021 and is valued at Rs 6.28 billion , according to the research firm. HYDERABAD: Demand for weight-loss drugs is rising at a fast clip in India, where rivals Eli Lilly and Novo Nordisk are competing for market...
by AIP Online Bureau | Dec 28, 2024 | Health, Regulation, Risk Management
Besides, 70 drug samples tested by the state drugs testing laboratories have also been identified as NSQ in November, they official sources said New Delhi: Central Drugs Standard Control Organisation (CDSCO) has found 41 drug samples tested in the central drug...
by AIP Online Bureau | Oct 29, 2024 | Eco/Invest/Demography, Health, Indian News, Policy, Regulation
In line with the government’s commitment to ensure the availability of drugs at affordable prices, the National Pharmaceutical Pricing Authority (NPPA) has issued an office memorandum directing the concerned manufacturers to reduce the MRP on three anti-cancer...
